Načítá se...
Management of patients with HBeAg‐negative chronic hepatitis B
Chronic hepatitis B (CHB) is one of the leading causes of morbidity and mortality worldwide. Although various drugs are available for the treatment of CHB, emergence of the hepatitis B e antigen (HBeAg)‐negative mutant variant, specifically in Asia, the Middle East and southern Europe, is creating a...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2599959/ https://ncbi.nlm.nih.gov/pubmed/17267676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/pgmj.2006.044826 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|